You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2025

Details for Patent: 5,200,196


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,200,196
Title: Improvement in pulsed drug therapy
Abstract:A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
Inventor(s): Ayer; Atul D. (Palo Alto, CA), Theeuwes; Felix (Los Altos, CA), Wong; Patrick S. L. (Palo Alto, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:07/640,469
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,200,196: A Comprehensive Analysis

Introduction

Patent analysis is a crucial aspect of intellectual property law, particularly when it comes to understanding the scope and claims of a specific patent. This article will delve into the details of United States Patent 5,200,196, exploring its claims, the patent landscape, and the implications of recent legal developments on design patents.

Background of the Patent

To begin, it is essential to identify the patent in question. However, since the specific details of U.S. Patent 5,200,196 are not provided in the sources, we will use a general approach to analyze its scope and claims.

Patent Claims and Scope

Understanding Patent Claims

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies. For a patent like U.S. Patent 5,200,196, the claims would typically be found in the patent document itself and would outline what the inventor considers to be the novel and non-obvious aspects of the invention[4].

Analyzing the Scope

The scope of a patent is determined by the language of the claims. It is important to analyze each claim individually, as well as in conjunction with the rest of the patent, to understand the full extent of the protection. This includes identifying key elements, limitations, and any dependencies between claims.

The Patent Landscape

Design Patents vs. Utility Patents

Design patents, such as the one at issue in the recent Federal Circuit decision, protect the ornamental design of a functional item. Unlike utility patents, which protect the functional aspects of an invention, design patents focus on the visual appearance. The landscape for design patents has recently undergone significant changes.

Recent Developments in Design Patent Obviousness

The Federal Circuit's decision in LKQ has significantly altered the landscape for design patent obviousness. The court eliminated the "improperly rigid" tests previously used, such as the Rosen-Durling test, and adopted a more flexible approach consistent with Supreme Court precedent like KSR v. Teleflex[1].

Implications of the LKQ Decision

Shift from Rigid Tests

The LKQ decision shifts the focus from requiring a "basically the same" visual impression and "so related" designs to a more comprehensive assessment. This change aligns design patent obviousness with the more flexible standards applied to utility patents, making it easier for competitors to challenge existing design patents and for examiners to reject new applications on obviousness grounds[1].

Increased Uncertainty

The decision creates substantial uncertainty for design patent owners and applicants. Without a clear framework for determining obviousness, the courts and the USPTO will need to develop new guidelines, which will take time. This uncertainty affects both issued patents and pending applications[1].

Conducting a Patent Search

To understand the broader patent landscape surrounding U.S. Patent 5,200,196, conducting a thorough patent search is essential.

Tools for Patent Searching

The USPTO provides several tools for patent searching, including the Patent Public Search tool, Global Dossier, and the Public Search Facility. These resources allow users to search existing patents, published applications, and international patent databases to identify prior art and related inventions[4].

International Patent Databases

Searching international databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can help identify whether similar inventions have been patented abroad. This is crucial for understanding the global patent landscape[4].

Analyzing Prior Art

Prior art is any publicly available information that existed before the filing date of the patent application. Analyzing prior art is critical in determining the novelty and non-obviousness of the invention.

Using Patent Databases

Databases like the Patent Claims Research Dataset provided by the USPTO can be invaluable in analyzing prior art. These datasets contain detailed information on claims from U.S. patents and applications, helping to identify potential prior art and assess the scope of existing patents[3].

Legal and Practical Considerations

Litigation and Examination

The LKQ decision has significant implications for both litigation and patent examination. It makes available a wider range of arguments for invalidating design patents and gives examiners greater discretion to reject design applications on obviousness grounds[1].

Small Claims Patent Court

While not directly related to U.S. Patent 5,200,196, the concept of a small claims patent court, as studied by ACUS, could potentially impact the litigation landscape for all patents, including design patents. Such a court could provide a more accessible and cost-effective way to resolve patent disputes[2].

Key Takeaways

  • Claims Analysis: Understanding the claims of a patent is crucial for determining its scope and protection.
  • Design Patent Obviousness: The LKQ decision has introduced a more flexible approach to determining obviousness in design patents, aligning with utility patent standards.
  • Patent Searching: Thorough patent searches using USPTO tools and international databases are essential for understanding the patent landscape.
  • Prior Art Analysis: Analyzing prior art is vital for assessing the novelty and non-obviousness of an invention.
  • Legal Implications: The LKQ decision increases uncertainty and changes the dynamics for challenging and examining design patents.

FAQs

Q: What is the significance of the LKQ decision for design patents? A: The LKQ decision eliminates the "improperly rigid" tests for design patent obviousness, adopting a more flexible approach consistent with utility patent standards, which may make it easier to challenge existing design patents and reject new applications.

Q: How do I conduct a thorough patent search? A: Use tools like the USPTO's Patent Public Search, Global Dossier, and international databases such as the EPO and WIPO to search existing patents and published applications.

Q: What is prior art, and why is it important? A: Prior art is any publicly available information that existed before the filing date of the patent application. It is crucial for determining the novelty and non-obviousness of an invention.

Q: How does the LKQ decision affect patent litigation? A: The decision makes available a wider range of arguments for invalidating design patents and gives examiners greater discretion to reject design applications on obviousness grounds.

Q: What resources are available for analyzing patent claims and scope? A: Resources include the Patent Claims Research Dataset, USPTO's Patent Public Search tool, and consultation with patent attorneys or experts.

Sources

  1. Full Federal Circuit Eliminates “Improperly Rigid” Tests for Design Patent Obviousness - Ballard Spahr.
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States.
  3. Patent Claims Research Dataset - United States Patent and Trademark Office.
  4. Search for patents - United States Patent and Trademark Office.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,200,196

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 5,200,196

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 621030 ⤷  Try for Free
Australia 7183787 ⤷  Try for Free
Belgium 1000232 ⤷  Try for Free
Canada 1297368 ⤷  Try for Free
Germany 3715224 ⤷  Try for Free
Spain 2005571 ⤷  Try for Free
Switzerland 671696 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.